QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 transcode-achieves-phase-1a-safety-milestone-for-ttx-mc138-advancing-to-phase-2a-after-durability-and-disease-control-in-cancer-patients

Safety primary endpoint achievedMedian treatment duration of 4 months with a range of 2 to 12 months and three patients remain ...

 transcode-makes-bold-bet-on-melanoma-vaccine-with-polynoma-buyout

TransCode Therapeutics Inc. (NASDAQ: RNAZ) to acquire Polynoma LLC and receive $25 million investment from CK Life Sciences.

 transcode-therapeutics-signs-agreement-to-acquire-polynoma-for-20m-cash-5m-promissory-note

BOSTON and SAN DIEGO, Oct. 8, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) ("TransCode or the "Comp...

 reported-may-14-2025-transcode-therapeutics-q1-eps-251-misses-200-estimate

TransCode Therapeutics (NASDAQ:RNAZ) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate...

 us-stocks-likely-to-open-lower-after-sp-500s-9-day-streak-any-de-escalation-in-trade-tensions-should-be-positive-says-expert

U.S. stock futures fell on Monday after a nine-day winning streak on the S&P 500 index. Futures of benchmark indices were l...

 transcode-therapeutics-announces-1-for-28-reverse-stock-split-the-effective-date-of-the-reverse-stock-split-has-not-yet-been-determined

Split designed to achieve compliance with Nasdaq minimum bid price requirementsBOSTON, May 2, 2025 /PRNewswire/ -- TransCode Th...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION